Mitogen-activated protein kinases in heart development and diseases

Area of Science:

• Cardiovascular Biology
• Molecular Cell Biology
• Biochemistry

Background:

• Mitogen-activated protein (MAP) kinases are crucial Ser-Thr protein kinases involved in diverse physiological functions.
• Key MAP kinase pathways (ERK1/2, JNK, p38, ERK5) are implicated in cardiac regulation, development, and pathological remodeling.
• Recent advances in kinase inhibitors and animal models offer new insights into cardiac MAP kinase functions.

Purpose of the Study:

• To review recent studies on MAP kinase subfamilies in cardiac development, hypertrophy, and survival.
• To address controversies regarding the protective or detrimental roles of specific MAP kinases in cardiac pathology.
• To evaluate the potential of targeting MAP kinases for heart disease therapies.

Main Methods:

• Literature review of recent studies on MAP kinase pathways in the heart.
• Analysis of data from kinase-specific inhibitors and genetically engineered animal models.
• Synthesis of information on MAP kinase roles in cardiac development, hypertrophy, and survival.

Main Results:

• MAP kinase pathways have diverse and sometimes contradictory roles in cardiac processes.
• Specific MAP kinases can act as either detrimental promoters or critical protectors during cardiac pathological conditions.
• Significant new insights have emerged, but controversies remain regarding their precise functions.

Conclusions:

• MAP kinase pathways are critical regulators of cardiac function with complex roles in disease.
• Targeting MAP kinases presents a potential therapeutic strategy for heart diseases, but requires careful consideration of specific pathways.
• Further research is needed to resolve existing controversies and optimize therapeutic approaches.